Print Books

eBooks

This acclaimed book describes the convergence of scientific, political, regulatory, and commercial factors that drive the biotechnology industry and define its scope.

In addition to its popularity among business professionals and scientists seeking to apply their skills to biotechnology, Building Biotechnology has also been adopted as a course text in dozens of advanced biotechnology programs including MBA programs at UC Irvine, Tepper, and Boston University; the Johns Hopkins biotechnology MS/MBA program; NIH Office of Technology Transfer; extension programs at Berkeley and UCSF; and international programs at the Karolinska Institute, Macquarie University, and Schulich School of Business.

This fourth edition significantly expands upon the foundation laid by the first three, updating case law and business models in this dynamic industry and adding significantly more case studies, informative figures and tables. Most importantly, Building Biotechnology enables seasoned business professionals and entrepreneurial scientists alike to understand the drivers of biotechnology businesses and apply their established skills for commercial success.

A very valuable, readable, clear, comprehensive and up to date guide of the biotechnology industry. Building Biotechnology is a must read for investors, reporters, directors and other laymen that wish to understand the fundamentals of the biotechnology business.

William A. Haseltine, Ph.D.

Founder and former Chairman & CEO, Human Genome Sciences, Inc.

The need for a comprehensive guide to understanding the inner workings of corporate biotechnology is very acute … This book does much to fulfill that role.

Nature Biotechnology

An impressive compendium of information for people getting started in the biotechnology industry.

Foundation for Advanced Education in the Sciences (National Institutes of Health)

Fox School of Business (Temple)

Georgetown University

Georgia State University

Grand Valley State University

Hemchandracharya North Gujarat University (India)

Herguan University (India)

INTI International University (Malaysia)

Johns Hopkins MS/MBA

Karolinska Institute (Sweden)

Macquarie University (Australia)

Manipal College of Pharmaceutical Sciences (India)

Middle Tennessee State University

Miracosta College

Northeastern University

Oregon Health & Science University

Penn State Master of Biotechnology

SIES College of Management Sciences (India)

San Diego Miramar College

San Jose State University

Schulich School of Business (York University)

Shoreline Community College

Tecnoloco de Monterrey (Mexico)

Tepper School of Business (Carnegie Mellon)

The College of William & Mary

UC Berkeley Extension

UC Berkeley Law School

UC Davis

UC Irvine Healthcare Executive MBA

UCLA Extension

UCSF Center for Entrepreneurship

UNC Charlotte

University of Abertay Dundee (Scotland)

University of Bridgeport

University of Buffalo School of Management

University of Calgary

University of Connecticut

University of Dubai

University of Jyvaskyla (Finland)

University of Maryland University College

University of Poitiers (France)

University of Texas San Antonio

Virginia Commonwealth University

Wake Forest University Schools of Business

Washington State University

West Texas A&M University

About the Author

Yali Friedman, Ph.D., is founder of thinkBiotech and chief editor and publisher of the Journal of Commercial Biotechnology. His first book, Building Biotechnology, is used as a course text in dozens of biotechnology programs. His other books include Best Practices in Biotechnology Education and Best Practices in Biotechnology Business Development. He is also a member of the board of directors of AmericasHealth, serves on the science advisory board of Chakra Biotech, is an associate of the World Technology Network, and also serves as a judge for the Biotech Humanitarian Award and the Maryland Incubator Company of the Year Award.

Dr. Friedman has strong exposure to leading issues in international biotechnology. He created and continues to edit a global biotechnology innovation scorecard for Scientific American Worldview, a global biotechnology perspective profiling biotechnology industries and innovation capacity in dozens of countries, and has been invited to participate in biotechnology industry development forums for international groups such as APEC and the Asian Productivity Organization, and for individual countries such as Japan, Canada, Germany, the Philippines, and Turkey.

Dr. Friedman taught biotechnology management at the National Institutes of Health and continues to regularly guest-lecture for other biotechnology education programs. He writes and speaks on diverse topics such as biotechnology entrepreneurship, strategies to cope with a lack of management talent and capital when developing companies outside of established hubs, and new paradigms in technology-based economic development.

Dr. Friedman has a long history in biotechnology media. He created the first blog on the business of biotechnology for a NY Times company, which was named to Forbes 'Best of the Web' list. His other projects include the Student Guide to DNA Based Computers, sponsored by FUJI Television, BiotechBlog.com, and DrugPatentWatch.com, a pharmaceutical industry competitive intelligence service based on a business plan that was awarded second place in the Panasci Entrepreneurial Awards Competition.